Pressor Effects of L and D Enantiomers of NGnitro-arginine in Conscious Rats Are Antagonized by L- but Not D-arginine

YX WANG,T ZHOU,CCY PANG
DOI: https://doi.org/10.1016/0014-2999(91)90668-g
IF: 5.195
1991-01-01
European Journal of Pharmacology
Abstract:The effects of NG-nitro-L-arginine (L-NNA) and NGnitro-D-arginine (D-NNA) on mean arterial pressure (MAP) were studied in conscious, unrestrained rats. I.v. bolus of either L-NNA (1–64 mg/kg) or D-NNA (2–64 mg/kg) dose dependency increased MAP to similar maximum values of 55 ± 7 and 52 ± 4 mm Hg and with ed50 values of 4.0 ± 0.9 and 8.9 ± 1.2 mg/kg (P < 0.05), respectively. The time course of the MAP response to a single dose (32 mg/kg i.v. bolus) of L-NNA and D-NNA were also obtained. The presser effects of L-NNA and D-NNA each lasted > 2 h with the rise phase t1/2 of 5 and 27 min (P < 0.05). respectively. I.v. infusions (10 mg/kg per min) of L-arginine (L-Arg) and D-arginine (D-Arg) did not alter the presser response to noradrenaline nor angiotensin II. L-Arg but not D-Arg attenuated the pressor responses to both L-NNA and D-NNA. Therefore, both L-NNA and D-NNA are efficacious and long-lasting presser agents: the pressor effects of both can be antagonized by L-Arg but not D-Arg. Our results suggest that the presser effects of both L-NNA and D-NNA involve the L-Arg/nitric oxide pathway.
What problem does this paper attempt to address?